Tunneling nanotubes facilitate autophagosome transfer in the leukemic niche

por de Rooij, B, Polak, R, Stalpers, F, Pieters, R, den Boer, M L
Publicado 2017

In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia.

por Klumper, E., Pieters, R., den Boer, M. L., Huismans, D. R., Loonen, A. H., Veerman, A. J.
Publicado 1995

PKCζ and PKMζ are overexpressed in TCF3-rearranged paediatric acute lymphoblastic leukaemia and are associated with increased thiopurine sensitivity

por Hartsink-Segers, S A, Beaudoin, J J, Luijendijk, M W J, Exalto, C, Pieters, R, Den Boer, M L
Publicado 2015

Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia

por van der Veer, A, van der Velden, V H J, Willemse, M E, Hoogeveen, P G, Petricoin, E F, Beverloo, H B, Escherich, G, Horstmann, M A, Pieters, R, den Boer, M L
Publicado 2014

Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target

por Hartsink-Segers, S A, Zwaan, C M, Exalto, C, Luijendijk, M W J, Calvert, V S, Petricoin, E F, Evans, W E, Reinhardt, D, de Haas, V, Hedtjärn, M, Hansen, B R, Koch, T, Caron, H N, Pieters, R, Den Boer, M L
Publicado 2013

RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia

por Jerchel, I S, Hoogkamer, A Q, Ariës, I M, Steeghs, E M P, Boer, J M, Besselink, N J M, Boeree, A, van de Ven, C, de Groot-Kruseman, H A, de Haas, V, Horstmann, M A, Escherich, G, Zwaan, C M, Cuppen, E, Koudijs, M J, Pieters, R, den Boer, M L
Publicado 2018